F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES for F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 21, 2008 | $1,296,417 | Replaced |
| 1st Quarter - Amendment | Nov 12, 2008 | $1,332,417 | Replaced |
| 1st Quarter - Amendment (this page) | Aug 24, 2009 | $1,332,417 | Yes |
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Housing HOU
Housing Federal position on molding
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM DANIEL | Director, Diagnostics |
Health Issues HCR
Pandemic Preparedness; Reimbrusement and general health issues; Prescription drug coverage and reimbursement issues; Early Treatment for HIV Act. Legislation on public health preparedness and response related to pandemic influenza. S.1445 and H.R. 2552, Senate and House versions of the Hepatitis C Epidemic Control and Prevention Act. Influenza Pandemic Preparednessness federal, state and local levels; Federal lobbying for Tamiflu and Actermra and pandemic flu funding; lobbying for the federal government's purchase and stockpiling of Tamiflu. FY 08 Emergency Supplemental Appropriations related preparedness for pandemic influenza.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARIN GARDNER | Director of Federal Government Affairs |
| ANNA GRIFFIN | Director of Federal Government Affairs |
| EVAN MORRIS | Vice President |
| JAMES SCOTT | Director of Federal Government Affairs |
Veterans VET
VA standardization of purchasing policies relating to blood glucose equipment.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANTHONY CALLAWAY | Director, Diagnostics |
Medicare/Medicaid MMM
Medicare coverage of and reimbursement for pharmaceuticals in Parts B&D, including oncology, rheumatoid arthritis adn ESRD; Medicare durable medical equipment reimbursement and policy Medicare laboratory reimbursement and policy, including provisions in: H.R. 1321/S.2404, the Medicare Advance Laboratory Diagnostics Act of 2007; H.R> 3453/S.2099 (to repeal the Medicare competitive bidding project for clinical; laboratory services); comparative effectiveness policies, including provisions in H.R.3162 the Children's Health and Medicare Protection Act of 2007; Medicare coverage policy for blood glucose monitors and test strips; Medicare payments for diagnostic tests; Emergency preparedness for influenza pandemic; DACC/Competitive Bidding; lobbied activities of the PST Coalition. The PST Coalition lobbied Congress and CMS on matters related to reimbursement for and coverage of home prothrombin time testing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANTHONY CALLAWAY | Director, Diagnostics |
| KATHLEEN A CLAESSENS New | Director, Diagnostics |
| WILLIAM DANIEL | Director, Diagnostics |
| ANNA GRIFFIN | Director, Federal Government Affairs |
| JAMES SCOTT | Director, Federal Government Affairs |
Budget/Appropriations BUD
BUD-FY09 Labor, HHS and Education Appropriation related to preparedness for pandemic influenza, HIV/AIDS programs and HCV screening, care and treatment. FY 09 Homeland Security Appropriations related to preparedness for pandemic influenza; S. Con Res 70 budget resolution; federal budget; issue concerning homeland security in regards to pandemic flu preparedness.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARIN GARDNER | Director, Federal Govenrment Affairs |
| ANNA GRIFFIN | Director, Federal Government Affairs |
| EVAN MORRIS | Vice President, Federal Government Affairs |
| JAMES SCOTT | Director, Federal Government Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.